PDLI - PDL BioPharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts1112
Avg. Estimate0.10.08-0.66-0.06
Low Estimate0.10.08-0.66-0.42
High Estimate0.10.08-0.660.3
Year Ago EPS-0.04-0.16-0.59-0.66
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts1122
Avg. Estimate1.5M2.5M14.6M31.3M
Low Estimate1.5M2.5M11.7M30M
High Estimate1.5M2.5M17.49M32.6M
Year Ago SalesN/A33.86M85.83M14.6M
Sales Growth (year/est)N/A-92.60%-83.00%114.40%
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.0.040.050.050.05
EPS Actual-0.04-0.16-0.48-0.26
Difference-0.08-0.21-0.53-0.31
Surprise %-200.00%-420.00%-1,060.00%-620.00%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate0.10.08-0.66-0.06
7 Days Ago0.10.08-0.66-0.06
30 Days Ago0.10.08-0.66-0.06
60 Days Ago0.050.030.070.1
90 Days Ago0.050.030.070.1
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesPDLIIndustrySector(s)S&P 500
Current Qtr.350.00%N/AN/AN/A
Next Qtr.150.00%N/AN/AN/A
Current Year-11.90%N/AN/AN/A
Next Year90.90%N/AN/AN/A
Next 5 Years (per annum)14.00%N/AN/AN/A
Past 5 Years (per annum)-38.44%N/AN/AN/A